Literature DB >> 14683626

Treatment or prevention of complications of acute ischemic stroke.

L J Kappelle1, H B Van Der Worp.   

Abstract

Both neurologic and medical complications influence outcome after stroke. Space-occupying supratentorial infarcts can cause transtentorial or uncal herniation, which leads to death. Treatments aimed at reducing intracranial pressure in patients with such infarcts are of unproven value. Mass-producing cerebellar infarction may lead to brainstem compression and obstructive hydrocephalus. These lesions often are treated surgically. Although anticonvulsants are not indicated for prophylaxis, the occurrence of epileptic seizures mandates treatment to prevent recurrences. Depression is common in the acute stage of stroke, but is probably not more prevalent after stroke than after myocardial infarction. Although dysphagia is common, it usually is a transient problem. Patients with a decrease of consciousness or brainstem dysfunction usually need tube feeding for a certain period of time. Medical complications, such as fever, infections, hyperglycemia, cardiac disorders, pressure sores, and deep venous thrombosis, are associated with a poor prognosis and should be treated as early as possible. Measures to prevent these complications are part of general care. Hypertension is very common during the week after stroke and should be treated only in case of extremely high values or malignant hypertension. A multidisciplinary approach in the stroke unit is necessary to prevent and manage complications in the acute phase of stroke.

Entities:  

Mesh:

Year:  2004        PMID: 14683626     DOI: 10.1007/s11910-004-0009-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  48 in total

Review 1.  Early assessments of dysphagia and aspiration risk in acute stroke patients.

Authors:  Deborah J C Ramsey; David G Smithard; Lalit Kalra
Journal:  Stroke       Date:  2003-04-03       Impact factor: 7.914

2.  Effect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery.

Authors:  T Steiner; T Friede; A Aschoff; P D Schellinger; S Schwab; W Hacke
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

3.  Blood pressure and clinical outcomes in the International Stroke Trial.

Authors:  Jo Leonardi-Bee; Philip M W Bath; Stephen J Phillips; Peter A G Sandercock
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study.

Authors:  M Jauss; D Krieger; C Hornig; J Schramm; O Busse
Journal:  J Neurol       Date:  1999-04       Impact factor: 4.849

5.  A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction.

Authors:  I Aben; F Verhey; J Strik; R Lousberg; J Lodder; A Honig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

Review 6.  The role of hyperglycemia in acute stroke.

Authors:  N Kagansky; S Levy; H Knobler
Journal:  Arch Neurol       Date:  2001-08

7.  Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study.

Authors:  L P Kammersgaard; H S Jørgensen; J A Rungby; J Reith; H Nakayama; U J Weber; J Houth; T S Olsen
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

8.  Timing for fever-related brain damage in acute ischemic stroke.

Authors:  J Castillo; A Dávalos; J Marrugat; M Noya
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

9.  Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor?

Authors:  Andrea Semplicini; Andrea Maresca; Gabriele Boscolo; Michelangelo Sartori; Roberta Rocchi; Valter Giantin; Pier Luigi Forte; Achille C Pessina
Journal:  Arch Intern Med       Date:  2003-01-27

Review 10.  Electrocardiographic changes in patients with acute stroke: a systematic review.

Authors:  George Khechinashvili; Kjell Asplund
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.